Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
CNCanton Strategic Holdings Inc logo

Canton Strategic Holdings Inc (CNTN)

NASDAQ Capital Market · Currency in USD
$1.86 ▲ +0.00 (+0.00%)
At close: Oct 23, 4:00 PM ET. Market closed.
$1.88 ▲ +0.02 (+1.08%)
After hours: Oct 23, 7:40 PM ET

Summary

Previous Close
$1.86
Open
$1.85
Day's Range
$1.82 – $1.89
52 Week Range
$1.66 – $6.89
Volume
327,987
Avg. Volume
869,679
Market Cap
$148.21M
Beta (5Y Monthly)
1.48
PE Ratio (TTM)
--
EPS (TTM)
-$0.45
Earnings Date
Nov 16, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Canton Strategic Holdings Inc

Sector
Healthcare
Industry
Biotechnology
Full-time employees
12
CEO
Mark Wendland

Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development.

Earnings

Next report: Mon, Nov 16, 2026
EPS estimate -$86.25 · Revenue est. $1.50M
DateEst.Actual
Aug 14, 2026–$0.01
May 13, 2026–-$0.17
Mar 31, 2026-$0.42-$2.02Miss
Nov 12, 2025-$0.43-$0.34Beat
Aug 14, 2025-$0.58-$0.64Miss
May 12, 2025-$0.84-$0.99Miss

Analyst view

Rating: Hold
Buy 0% · Hold 100% · Sell 0%

Get free alerts on CNTN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.